Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience.
Klaassen R, Steins A, Gurney-Champion OJ, Bijlsma MF, van Tienhoven G, Engelbrecht MRW, van Eijck CHJ, Suker M, Wilmink JW, Besselink MG, Busch OR, de Boer OJ, van de Vijver MJ, Hooijer GKJ, Verheij J, Stoker J, Nederveen AJ, van Laarhoven HWM. Klaassen R, et al. Among authors: van laarhoven hwm, van tienhoven g, van de vijver mj, van eijck chj. Mol Oncol. 2020 Sep;14(9):2176-2189. doi: 10.1002/1878-0261.12688. Epub 2020 Jun 23. Mol Oncol. 2020. PMID: 32285559 Free PMC article.
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.
Voogd AC, van Oost FJ, Rutgers EJ, Elkhuizen PH, van Geel AN, Scheijmans LJ, van der Sangen MJ, Botke G, Hoekstra CJ, Jobsen JJ, van de Velde CJ, von Meyenfeldt MF, Tabak JM, Peterse JL, van de Vijver MJ, Coebergh JW, van Tienhoven G; Dutch Study Group on Local Recurrence after Breast Conservation (BORST Group). Voogd AC, et al. Among authors: van oost fj, van de vijver mj, van tienhoven g, van geel an, van de velde cj, van der sangen mj. Eur J Cancer. 2005 Nov;41(17):2637-44. doi: 10.1016/j.ejca.2005.04.040. Epub 2005 Aug 22. Eur J Cancer. 2005. PMID: 16115758
Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?
Russell NS, Kunkler IH, van Tienhoven G, Canney PA, Thomas J, Bartlett J, van de Vijver MJ, Belkacemi Y, Yarnold JR, Barrett-Lee PJ. Russell NS, et al. Among authors: van tienhoven g, van de vijver mj. J Clin Oncol. 2009 Feb 20;27(6):996-7; author reply 997-8. doi: 10.1200/JCO.2008.18.7062. Epub 2009 Jan 21. J Clin Oncol. 2009. PMID: 19164209 No abstract available.
Position verification for the prostate: effect on rectal wall dose.
Haverkort MA, van de Kamer JB, Pieters BR, van Tienhoven G, Assendelft E, Lensing AL, van Herk M, de Reijke TM, Stoker J, Koning CC. Haverkort MA, et al. Among authors: van tienhoven g, van herk m, van de kamer jb. Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):462-8. doi: 10.1016/j.ijrobp.2010.02.016. Epub 2010 Jun 18. Int J Radiat Oncol Biol Phys. 2011. PMID: 20646865
Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer.
Morak MJ, Richel DJ, van Eijck CH, Nuyttens JJ, van der Gaast A, Vervenne WL, Padmos EE, Schaake EE, Busch OR, van Tienhoven G. Morak MJ, et al. Among authors: van eijck ch, van tienhoven g, van der gaast a. Radiother Oncol. 2011 Feb;98(2):261-4. doi: 10.1016/j.radonc.2010.10.016. Epub 2010 Nov 12. Radiother Oncol. 2011. PMID: 21075468 Clinical Trial.
Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer.
Klaassen R, Bennink RJ, van Tienhoven G, Bijlsma MF, Besselink MG, van Berge Henegouwen MI, Wilmink JW, Nederveen AJ, Windhorst AD, Hulshof MC, van Laarhoven HW. Klaassen R, et al. Among authors: van laarhoven hw, van tienhoven g, van berge henegouwen mi. Radiother Oncol. 2015 Jul;116(1):94-9. doi: 10.1016/j.radonc.2015.05.009. Epub 2015 Jun 3. Radiother Oncol. 2015. PMID: 26049919 Free article.
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer.
van Zweeden AA, van der Vliet HJ, Wilmink JW, Meijerink MR, Meijer OW, Bruynzeel AM, van Tienhoven G, Giovannetti E, Kazemier G, Jacobs MA, Verheul HM. van Zweeden AA, et al. Among authors: van der vliet hj, van tienhoven g. Clin Cancer Res. 2015 Oct 15;21(20):4569-75. doi: 10.1158/1078-0432.CCR-14-3364. Epub 2015 Jun 8. Clin Cancer Res. 2015. PMID: 26056353 Clinical Trial.
195 results